Intrinsic Value

The intrinsic value of Rockwell Medical Inc (RWM) under the Base Case is 2.49 EUR per share. Compared with the current market price of 1.27 EUR, the stock appears Undervalued by 49% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

RWM Intrinsic Value
€2.49
Undervaluation 49%
Intrinsic Value
Price €1.27
Alert me when RWM is below its intrinsic value
Today €1.24 · 2.1% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to RWM

Fundamental Analysis

What Rockwell Medical Does

Health Care

Rockwell Medical makes products used to clean the blood of patients with kidney failure during hemodialysis treatment. Its main products include liquid and dry acid concentrates, bicarbonate products, and other dialysis-related supplies that dialysis clinics use to prepare the fluids delivered in treatment. The company sells these products to dialysis providers, hospitals, and other healthcare customers that need a steady supply of dialysate ingredients and related consumables.

Headquarters
United States of America US
Employees
157
IPO date
Jan 27, 1998
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Rockwell Medical Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

RMTI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RWM stock?

The intrinsic value for Rockwell Medical Inc (RWM) under the Base Case is 2.49 EUR.

Is RWM stock undervalued or overvalued?

Compared with the current market price of 1.27 EUR, the stock appears Undervalued by 49% .

Back to Top